Skip to main content
UniHealth

Doctor search

Paul B. Eckburg, MD

Infectious Disease · Stanford

NPI 1740316900

Medicare standing
1 flag on the record
Listed below.
Plans that list them
Not verified
Not the same as out of network.
Office
1

On the public record

  • Medicare does not list them as allowed to order and refer

Offices

1 location

Plan participation

Not verified

We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Eckburg’s office at (650) 723-4000 to ask if they take your plan before you enroll.

California Medical Board record

Licence A63142 · Current

Licensed to practise in California · since 1997 · expires 2029-02-28 · Rush Medical College of Rush University.

No disciplinary actions, convictions, malpractice judgments or citations in this record.

Money from drug and device companies

$2,560 in 2025

Industry payments by year
202512$2,560$2,560
202211$2,800$2,800
202115$6,500$6,500
202019$41,550$41,550
201914$44,250$44,250

Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.

A payment is not proof that care is biased.

Payments by company
GenentechNone$2,560
2 payments
  • Consulting · 2025-06-26 · $1,280
  • Consulting · 2025-06-03 · $1,280
See all 2 published payments
Every published payment
GenentechConsulting · 2025-06-26None$1,280
GenentechConsulting · 2025-06-03None$1,280
See earlier years (2022, 2021, 2020, 2019)

2022: $2,800

Payments by company in 2022
Paratek PharmaceuticalsNuzyra$2,800
1 payment
  • Consulting for Nuzyra · 2022-06-07 · $2,800

2021: $6,500

Payments by company in 2021
Paratek PharmaceuticalsNuzyra$6,500
5 payments
  • Consulting for Nuzyra · 2021-09-27 · $800
  • Consulting for Nuzyra · 2021-07-27 · $1,350
  • Consulting for Nuzyra · 2021-05-25 · $1,650
  • Consulting for Nuzyra · 2021-02-23 · $1,350
  • Consulting for Nuzyra · 2021-01-12 · $1,350

2020: $41,550

Payments by company in 2020
Paratek PharmaceuticalsNuzyra$41,550
9 payments
  • Consulting for Nuzyra · 2020-10-27 · $1,500
  • Consulting for Nuzyra · 2020-09-11 · $4,500
  • Consulting for Nuzyra · 2020-09-03 · $1,800
  • Consulting for Nuzyra · 2020-07-15 · $6,000
  • Consulting for Nuzyra · 2020-05-06 · $4,350
  • Consulting for Nuzyra · 2020-04-03 · $4,050
  • Consulting for Nuzyra · 2020-03-04 · $5,250
  • Consulting for Nuzyra · 2020-02-04 · $10,350
  • Consulting for Nuzyra · 2020-01-14 · $3,750

2019: $44,250

Payments by company in 2019
Paratek PharmaceuticalsNuzyra$44,250
4 payments
  • Consulting for Nuzyra · 2019-11-26 · $8,850
  • Consulting for Nuzyra · 2019-10-22 · $7,050
  • Consulting for Nuzyra · 2019-10-01 · $10,950
  • Consulting for Nuzyra · 2019-08-20 · $17,400

Professional record

NPI
1740316900
Licence
CA A63142California A63142: Current · expires 2029-02-28
More record details
Sole proprietor
No
Medicaid ID
CA 00A631420
Taxonomy
Federal specialty code 207RI0200X (207RI0200X)
Mailing address
2680 Hanover St, Palo Alto, CA, 94304
NPI first listed
2007-02-24
NPI last updated
2008-04-04

This is when the NPI record was last certified, not a medical board exam.